This inventor holds 3 USPTO granted patents. Top assignee: Suntory Limited. Active years: 1981-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toyonaka, JP (1981 - 1984)
- Osaka, JP (1985)
Company Filing History:
Years Active: 1981-1985
Title: Akira Hakura: Innovator in Carcinostatic Agents
Introduction
Akira Hakura is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of carcinostatic agents. With a total of 3 patents to his name, Hakura's work has the potential to impact cancer treatment significantly.
Latest Patents
Hakura's latest patents include a polypeptide carcinostatic agent, which contains a polypeptide of a specific formula. This agent is designed to treat transplanted tumors in mice. His research focuses on novel polypeptides that serve as carcinostatic agents and as tools for the detection and determination of viruses. The polypeptides he developed consist of forty-five amino acid residues and feature a unique tetracyclic structure, bridged by four disulfide bonds between specific cysteine molecular pairs.
Career Highlights
Hakura is currently employed at Suntory Limited, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in cancer therapy and viral detection.
Collaborations
Hakura collaborates with esteemed colleagues, including Kumao Toyoshima and Toshihiro Nakanishi, who contribute to his research endeavors.
Conclusion
Akira Hakura's contributions to the development of carcinostatic agents highlight his role as a significant innovator in biotechnology. His work not only advances scientific understanding but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile